Bowel Drug False Ad Suit Kept Alive

Two pharmaceutical companies are still locked in a false advertising and trademark feud over a colonoscopy bowel preparation drug, after a Massachusetts federal judge said Tuesday that there were still factual...

Already a subscriber? Click here to view full article